BARBARA BERGESKI: Open Payments
NPI 1295705382 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 44 payments from 14 companies in 2025. Trend: 2023 $1,087 · 2024 $1,311 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $369 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| ABBVIE INC. | 4 | $100 |
| PFIZER INC. | 4 | $77 |
| Lilly USA, LLC | 4 | $70 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Astellas Pharma US Inc | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
Products named: Ozempic, REXULTI, JARDIANCE, Saxenda, TRELEGY ELLIPTA, Veozah, Rybelsus, LINZESS.
Industry payments across MI — which companies pay providers there.
